椎間板変性疾患市場：製品タイプ、治療、エンドユーザー別-2025～2030年の世界予測

椎間板変性疾患市場は、2023年に20億2,000万米ドルと評価され、2024年には21億7,000万米ドルに達すると予測され、CAGR 7.73％で成長し、2030年には34億1,000万米ドルになると予測されています。

椎間板変性疾患（DDD）は、椎間板の磨耗と断裂から生じる病態を包含し、一般的には加齢に起因するが、傷害や遺伝的要因によっても促進されます。この疾患は、激しい痛みや可動性の問題につながる可能性があります。世界の高齢化、座りっぱなしのライフスタイル、肥満率の上昇によってDDDの発生率が高まっているため、医療産業では、治療や外科的介入を革新するための研究開発への投資が増加しています。適用範囲は、整形外科クリニック、病院、専門のリハビリテーションセンターにまで及び、エンドユーザーは中等度から重度のDDDを患う患者です。市場開拓洞察によると、生物製剤の注射や再生医療のような非外科的介入とともに、低侵襲手術手技の継続的な開発が重要な成長要因となっています。また、画像診断やオーダーメイド治療計画のための人工知能の進歩も、大きな成長の牽引役となっています。

再生医療研究、特に幹細胞治療と軟骨再生は、非侵襲的な代替医療として有望であるため、ビジネス機会が到来しています。しかし、高い治療費、新しい治療法の承認における規制上のハードル、未発達地域における初期段階の疾患管理に対する認識不足などが、市場成長の課題となっています。さらに、技術の進歩にもかかわらず、新興市場におけるこのような先進的治療の普及は依然として限定的です。このような機会を生かすための調査としては、コスト削減戦略に重点を置き、研究機関と医療技術企業との連携を強化し、イノベーションを迅速に進めることが挙げられます。DDDの早期発見と早期管理に関する認識を高めるための教育イニシアティブへの投資により、未開拓の大市場を確立することができます。市場の競争は激しいが有望であり、患者中心の治療や先進的な生物製剤にはイノベーションの余地が大きいです。利害関係者は、個別化医療、脊髄健康モニタリングのためのウェアラブル技術、患者データ分析のためのディープラーニング・アルゴリズムにおけるブレークスルーを今後の重要な開拓セグメントとして優先し、市場の持続的拡大と患者の転帰の改善を確保することが望まれます。

市場力学：急速に進化する椎間板変性疾患市場の主要市場洞察を公開

椎間板変性疾患市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネス機会の獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 椎間板変性疾患の増加
  • 非外科的治療オプションへの嗜好の高まり
  • 理学療法や鎮痛剤などの保存療法の利用可能性
• 市場抑制要因
  • 手術費用の高騰
• 市場機会
  • 椎間板変性疾患治療における技術の進歩
  • 外科手術におけるロボット技術の採用
• 市場課題
  • 代替療法の利用可能性

ポーターのファイブフォース：椎間板変性疾患市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：椎間板変性疾患市場における外部からの影響の把握

外部マクロ環境要因は、椎間板変性疾患市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：椎間板変性疾患市場における競合情勢の把握

椎間板変性疾患市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：椎間板変性疾患市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、椎間板変性疾患市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：椎間板変性疾患市場における成功への道筋を描く

椎間板変性疾患市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報に基づいた意思決定を行う上で役立つ重要な質問にも回答しています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 変性椎間板疾患の発生増加
    • 非外科的治療オプションの好感度が高まっている
    • 理学療法や鎮痛剤などの保存的療法の利用可能性
  • 抑制要因
    • 椎間板変性疾患手術の高額な費用
  • 機会
    • 椎間板変性疾患治療における技術的進歩
    • 外科手術におけるロボット技術の採用
  • 課題
    • 代替療法の利用可能性
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 椎間板変性疾患市場：製品タイプ別

• イントロダクション
• デバイス
  • 頸椎
  • 腰椎
  • 脊椎固定術
  • 胸椎
• 薬剤
  • アセトアミノフェン
  • 筋弛緩剤
  • NSAID
  • 経口ステロイド

第7章 椎間板変性疾患市場：治療別

• イントロダクション
• 人工椎間板置換術
• 頸椎
• 腰椎
• 脊椎固定術
• 胸椎

第8章 椎間板変性疾患市場：エンドユーザー別

• イントロダクション
• クリニック
• 病院

第9章 南北アメリカの椎間板変性疾患市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋の椎間板変性疾患市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの椎間板変性疾患市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AnGes MG, Inc.
• B. Braun SE
• Biopharm GmbH
• Cerapedics Inc.
• DePuy Synthes by Medical Device Business Services, Inc.
• Globus Medical Inc.
• Kolon TissueGene Inc.
• Lineage Cell Therapeutics, Inc.
• Medtronic PLC
• NLC Ventures Netherlands B.V.
• Notogen, Inc.
• Pfizer Inc.
• Smith & Nephew PLC
• Ulrich Medical USA Inc.
• Zimmer Biomet Holdings Inc.

LIST OF FIGURES

• FIGURE 1. DEGENERATIVE DISC DISEASE MARKET RESEARCH PROCESS
• FIGURE 2. DEGENERATIVE DISC DISEASE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. DEGENERATIVE DISC DISEASE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. DEGENERATIVE DISC DISEASE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DEGENERATIVE DISC DISEASE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DEGENERATIVE DISC DISEASE MARKET DYNAMICS
• TABLE 7. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY CERVICAL SPINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY LUMBAR SPINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY THORACIC SPINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY ACETAMINOPHEN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY MUSCLE RELAXANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY NSAIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORAL STEROIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY ARTIFICIAL DISC REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY CERVICAL SPINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY LUMBAR SPINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY THORACIC SPINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 45. CANADA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 46. CANADA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 47. CANADA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 48. CANADA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 49. CANADA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 72. CHINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 73. CHINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 74. CHINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 75. CHINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 76. CHINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 77. INDIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 78. INDIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 79. INDIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 80. INDIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 81. INDIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 163. ITALY DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 164. ITALY DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 165. ITALY DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 166. ITALY DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 167. ITALY DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 183. POLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 184. POLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 185. POLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 186. POLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 187. POLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 188. QATAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 189. QATAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 190. QATAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 191. QATAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 192. QATAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 238. DEGENERATIVE DISC DISEASE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 239. DEGENERATIVE DISC DISEASE MARKET, FPNV POSITIONING MATRIX, 2023

The Degenerative Disc Disease Market was valued at USD 2.02 billion in 2023, expected to reach USD 2.17 billion in 2024, and is projected to grow at a CAGR of 7.73%, to USD 3.41 billion by 2030.

Degenerative Disc Disease (DDD) encompasses a condition that arises from the wear-and-tear of intervertebral discs, commonly attributing to aging but also facilitated by injury and genetic factors. This condition can lead to severe pain and mobility issues. Necessitated by the growing incidence of DDD, driven by an aging global population, sedentary lifestyles, and rising obesity rates, the healthcare industry is increasingly investing in research and development to innovate therapeutic and surgical interventions. The application scope extends to orthopedic clinics, hospitals, and specialized rehabilitation centers with end-users being patients suffering from moderate to severe forms of DDD. Market insights reveal that continuous developments in minimally invasive surgical techniques, along with non-surgical interventions like biologic injections and regenerative medicines, are critical growth influencers. Advances in artificial intelligence for diagnostic imaging and tailored treatment plans also provide significant growth traction.

Opportunities emerge in regenerative medicine research, particularly stem cell therapy and cartilage regeneration, as they present promising non-invasive alternatives. However, market growth is challenged by high treatment costs, regulatory hurdles in approving new treatments, and a lack of awareness about early-stage disease management in underdeveloped regions. Moreover, despite technological advancements, the penetration of such sophisticated treatments in emerging markets remains limited. Recommendations for capitalizing on these opportunities include focusing on cost reduction strategies and increasing collaboration between research institutions and medical technology firms to fast-track innovation. Investment in educational initiatives to raise awareness about early detection and management of DDD can establish large untapped markets. The nature of the market is highly competitive yet promising, with substantial room for innovation in patient-centric therapies and advanced biologics. Stakeholders are encouraged to prioritize breakthroughs in personalized medicine, wearable technology for spinal health monitoring, and deep learning algorithms for patient data analysis as pivotal areas for future developments, ensuring sustained market expansion and improved patient outcomes.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Degenerative Disc Disease Market

The Degenerative Disc Disease Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising occurrences of degenerative disc disorders
  • Increasing preference for non-surgical treatment options
  • Availability of conservative therapies such as physical therapy, and pain relievers
• Market Restraints
  • High cost of degenerative disc disease surgeries
• Market Opportunities
  • Technological advancements in degenerative disc disease treatments
  • Introduction of robotic technology in surgical procedures
• Market Challenges
  • Availability of alternative therapies

Porter's Five Forces: A Strategic Tool for Navigating the Degenerative Disc Disease Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Degenerative Disc Disease Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Degenerative Disc Disease Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Degenerative Disc Disease Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Degenerative Disc Disease Market

A detailed market share analysis in the Degenerative Disc Disease Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Degenerative Disc Disease Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Degenerative Disc Disease Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Degenerative Disc Disease Market

A strategic analysis of the Degenerative Disc Disease Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Degenerative Disc Disease Market, highlighting leading vendors and their innovative profiles. These include AnGes MG, Inc., B. Braun SE, Biopharm GmbH, Cerapedics Inc., DePuy Synthes by Medical Device Business Services, Inc., Globus Medical Inc., Kolon TissueGene Inc., Lineage Cell Therapeutics, Inc., Medtronic PLC, NLC Ventures Netherlands B.V., Notogen, Inc., Pfizer Inc., Smith & Nephew PLC, Ulrich Medical USA Inc., and Zimmer Biomet Holdings Inc..

Market Segmentation & Coverage

This research report categorizes the Degenerative Disc Disease Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Devices and Drugs. The Devices is further studied across Cervical Spine, Lumbar Spine, Spinal Fusion, and Thoracic Spine. The Drugs is further studied across Acetaminophen, Muscle Relaxants, NSAIDs, and Oral Steroids.
• Based on Treatment, market is studied across Artificial Disc Replacement, Cervical Spine, Lumbar Spine, Spinal Fusion, and Thoracic Spine.
• Based on End-Users, market is studied across Clinics and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising occurrences of degenerative disc disorders
    • 5.1.1.2. Increasing preference for non-surgical treatment options
    • 5.1.1.3. Availability of conservative therapies such as physical therapy, and pain relievers
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of degenerative disc disease surgeries
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in degenerative disc disease treatments
    • 5.1.3.2. Introduction of robotic technology in surgical procedures
  • 5.1.4. Challenges
    • 5.1.4.1. Availability of alternative therapies
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Degenerative Disc Disease Market, by Product Type

• 6.1. Introduction
• 6.2. Devices
  • 6.2.1. Cervical Spine
  • 6.2.2. Lumbar Spine
  • 6.2.3. Spinal Fusion
  • 6.2.4. Thoracic Spine
• 6.3. Drugs
  • 6.3.1. Acetaminophen
  • 6.3.2. Muscle Relaxants
  • 6.3.3. NSAIDs
  • 6.3.4. Oral Steroids

7. Degenerative Disc Disease Market, by Treatment

• 7.1. Introduction
• 7.2. Artificial Disc Replacement
• 7.3. Cervical Spine
• 7.4. Lumbar Spine
• 7.5. Spinal Fusion
• 7.6. Thoracic Spine

8. Degenerative Disc Disease Market, by End-Users

• 8.1. Introduction
• 8.2. Clinics
• 8.3. Hospitals

9. Americas Degenerative Disc Disease Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Degenerative Disc Disease Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Degenerative Disc Disease Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AnGes MG, Inc.
• 2. B. Braun SE
• 3. Biopharm GmbH
• 4. Cerapedics Inc.
• 5. DePuy Synthes by Medical Device Business Services, Inc.
• 6. Globus Medical Inc.
• 7. Kolon TissueGene Inc.
• 8. Lineage Cell Therapeutics, Inc.
• 9. Medtronic PLC
• 10. NLC Ventures Netherlands B.V.
• 11. Notogen, Inc.
• 12. Pfizer Inc.
• 13. Smith & Nephew PLC
• 14. Ulrich Medical USA Inc.
• 15. Zimmer Biomet Holdings Inc.